ALLEN LONG: Open Payments
NPI 1578772828 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,798 in 73 payments from 20 companies in 2025. Trend: 2023 $2,531 · 2024 $2,286 · 2025 $1,798
Food & beverage: $1,798
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $441 |
| ACADIA Pharmaceuticals Inc | 13 | $263 |
| UCB, Inc. | 9 | $219 |
| Alexion Pharmaceuticals, Inc. | 1 | $124 |
| Neurelis, Inc. | 7 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $102 |
| TG Therapeutics, Inc. | 4 | $84 |
| ANI Pharmaceuticals, Inc. | 2 | $68 |
| Merz Pharmaceuticals, LLC | 3 | $64 |
| CSL Behring | 3 | $52 |
Products named: NUPLAZID, BOTOX, VYALEV, VALTOCO, HYQVIA, BRIUMVI, QULIPTA, Briviact.
Industry payments across FL — which companies pay providers there.
